Hot Investor Mandate: USA VC Invests in Therapeutics & Medical Device Technologies, With Strongest Interest in Therapeutics Solutions Targeting Unmet Medical Need

2 Dec

A Venture Capital firm based in USA manages 5 funds. With the latest fund, the firm looks to provide up to $3-4 million of preferred equity capital in the initial round and up to $6-8 million over the life of the investment. The firm generally looks for companies with lead assets that can reach a high value inflection point in 3-4 years. The firm will consider companies in North America.

The firm is currently looking for companies developing Therapeutics and Medical Technology. Within therapeutics which is the firms primary focus, companies with an asset anywhere from preclinical with positive animal data to Phase II will be considered. The firm is generally open to all technology types and indications with the exception of wound care and psychiatry. Within devices, the firm is currently looking for market approved product with early revenue; however, devices are not an investment priority at present. The firm is looking for companies targeting true un-met medical needs where either no treatment currently exists or the existing standard of care is wrought with side-effects and other impediments to quality care.

The firm does not have any specific requirement for a firm’s management team although they are an active investor looking to take a seat on the company’s board.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: